ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
4 |
19:08 |
19:08 |
ASX - By Stock
|
32
|
8.3K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
4 |
12:48 |
12:48 |
ASX - By Stock
|
32
|
8.3K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
682 |
255K |
24 |
12:34 |
12:34 |
ASX - By Stock
|
682
|
255K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
9 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
32
|
8.3K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
66 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
66
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
24 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
32
|
8.3K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
11 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
32
|
8.3K
|
11
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
23 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
32
|
8.3K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
hottod
|
32 |
8.3K |
26 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
32
|
8.3K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
64 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
64
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
53 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
53
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
22 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
hottod
|
21 |
11K |
19 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
21
|
11K
|
19
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
17 |
5.0K |
24 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
17
|
5.0K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
hottod
|
21 |
11K |
29 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
21
|
11K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
682 |
255K |
30 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
682
|
255K
|
30
|
|
ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
hottod
|
25 |
9.1K |
14 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
25
|
9.1K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
Pitt St Research Report...
|
|
hottod
|
25 |
9.1K |
17 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
25
|
9.1K
|
17
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
682 |
255K |
40 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
682
|
255K
|
40
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
2.8K |
1.2M |
27 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
27
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
hottod
|
123 |
55K |
39 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
123
|
55K
|
39
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
hottod
|
10 |
3.7K |
22 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
10
|
3.7K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
hottod
|
123 |
55K |
138 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
123
|
55K
|
138
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
59 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
59
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
20 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
56
|
15K
|
20
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
hottod
|
10 |
3.7K |
21 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
10
|
3.7K
|
21
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Chairman address to Bell Potter Healthcare Conference
|
|
hottod
|
60 |
17K |
40 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
60
|
17K
|
40
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
24 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
56
|
15K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
6 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
56
|
15K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Supplementary Information
|
|
hottod
|
7 |
1.7K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
7
|
1.7K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
47 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
47
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Supplementary Information
|
|
hottod
|
7 |
1.7K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
7
|
1.7K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
81 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
81
|
|
ASX - By Stock
|
AVE |
Re:
Ann: CEO Presentation
|
|
hottod
|
20 |
3.8K |
6 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
20
|
3.8K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
7 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
56
|
15K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
hottod
|
284 |
108K |
21 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
284
|
108K
|
21
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Chairman address to Bell Potter Healthcare Conference
|
|
hottod
|
60 |
17K |
4 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
60
|
17K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Chairman address to Bell Potter Healthcare Conference
|
|
hottod
|
60 |
17K |
36 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
60
|
17K
|
36
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Chairman address to Bell Potter Healthcare Conference
|
|
hottod
|
60 |
17K |
47 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
60
|
17K
|
47
|
|
ASX - By Stock
|
AVE |
Re:
CBD and Insomnia
|
|
hottod
|
18 |
2.9K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
18
|
2.9K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
hottod
|
36 |
8.9K |
4 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
36
|
8.9K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
48 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
56
|
15K
|
48
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
hottod
|
56 |
15K |
34 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
56
|
15K
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
8.0K |
3.4M |
58 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
8.0K
|
3.4M
|
58
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 November 2023
|
|
hottod
|
22 |
11K |
107 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
22
|
11K
|
107
|
|
ASX - By Stock
|
PNV |
Re:
Polymedics promoting Novsorb BTM
|
|
hottod
|
5 |
3.3K |
40 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
5
|
3.3K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 November 2023
|
|
hottod
|
22 |
11K |
32 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
22
|
11K
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 November 2023
|
|
hottod
|
22 |
11K |
43 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
22
|
11K
|
43
|
|
ASX - By Stock
|
NEU |
Re:
Phase 2
|
|
hottod
|
25 |
11K |
28 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
25
|
11K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Phase 2
|
|
hottod
|
25 |
11K |
53 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
25
|
11K
|
53
|
|